FDA clears Onward’s ARC-EX System for home use in spinal cord injury care

Having been commercially available for less than 12 months, the system is now offered in over 60 US clinics.

The US Food and Drug Administration (FDA) has granted 510(k) clearance for the expanded use of Onward Medical’s ARC-EX System, now permitting individuals with spinal cord injuries (SCI) to use the device at home, as well as in clinical settings.

This cleared indication covers adults with long-standing, non-progressive neurological impairments originating from an incomplete SCI, aiming to enhance hand strength and sensation through both supervised rehabilitation and home exercise routines.

Sign up for Blog Updates